Neutral Sphingomyelinase 1 Deficiency in the Mouse Causes No Lipid Storage Disease

REFERENCES

• Bligh, E., and W. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911–917.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
   PubMed Web of Science ®Google Scholar
• Dittmer, J., and R. Lester. 1964. A simple, specific spray for the detection of phospholipids on thin layer chromatography. J. Lipid Res. 5: 126–127.
   PubMed Web of Science ®Google Scholar
• Fensome, A. C., F. Rodrigues-Lima, M. Josephs, H. F. Paterson, and M. Katan. 2000. A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species. J. Biol. Chem. 275: 1128–1136.
   PubMedGoogle Scholar
• Gatt, S. 1976. Magnesium-dependent sphingomyelinase. Biochem. Biophys. Res. Commun. 68: 235–241.
   PubMed Web of Science ®Google Scholar
• Goni, F. M., and A. Alonso. 1999. Structure and functional properties of diacylglycerols in membranes. Prog. Lipid Res. 38: 1–48.
   PubMed Web of Science ®Google Scholar
• Hofmann, K., and V. M. Dixit. 1998. Ceramide in apoptosis--does it really matter? Trends Biochem. Sci. 23: 374–377.
   PubMed Web of Science ®Google Scholar
• Hofmann, K., S. Tomiuk, G. Wolff, and W. Stoffel. 2000. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc. Natl. Acad. Sci. USA 97: 5895–5900.
   PubMed Web of Science ®Google Scholar
• Horinouchi, K., S. Erlich, D. P. Perl, K. Ferlinz, C. L. Bisgaier, K. Sandhoff, R. J. Desnick, C. L. Stewart, and E. H. Schuchman. 1995. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 10: 288–293.
   PubMedGoogle Scholar
• Jones, D., C. Morgan, and S. Cockcroft. 1999. Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta 1439: 229–244.
   PubMed Web of Science ®Google Scholar
• Ledeen, R. W., and R. K. Yu. 1982. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83: 139–191.
   PubMed Web of Science ®Google Scholar
• Liu, B., L. M. Obeid, and Y. A. Hannun. 1997. Sphingomyelinases in cell regulation. Semin. Cell Dev. Biol. 8: 311–322.
   PubMedGoogle Scholar
• Mizutani, Y., K. Tamiya-Koizumi, F. Irie, Y. Hirabayashi, M. Miwa, and S. Yoshida. 2000. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. Biochim. Biophys. Acta 1485: 236–246.
   PubMedGoogle Scholar
• Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90: 8424–8428.
   PubMed Web of Science ®Google Scholar
• Neuberger, Y., H. Shogomori, Z. Levy, M. Fainzilber, and A. H. Futerman. 2000. A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. FEBS Lett. 469: 44–46.
   PubMedGoogle Scholar
• Newrzella, D., and W. Stoffel. 1996. Functional analysis of the glycosylation of murine acid sphingomyelinase. J. Biol. Chem. 271: 32089–32095.
   PubMedGoogle Scholar
• Newrzella, D., and W. Stoffel. 1992. Molecular cloning of the acid sphingomyelinase of the mouse and the organization and complete nucleotide sequence of the gene. Biol. Chem. Hoppe-Seyler 373: 1233–1238.
   PubMedGoogle Scholar
• Nix, M., and W. Stoffel. 2000. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ. 7: 413–424.
   PubMedGoogle Scholar
• Otterbach, B., and W. Stoffel. 1995. Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81: 1053–1061.
   PubMed Web of Science ®Google Scholar
• Quintern, L. E., E. H. Schuchman, O. Levran, M. Suchi, K. Ferlinz, H. Reinke, K. Sandhoff, and R. J. Desnick. 1989. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 8: 2469–2473.
   PubMedGoogle Scholar
• Quintern, L. E., G. Weitz, H. Nehrkorn, J. M. Tager, A. W. Schram, and K. Sandhoff. 1987. Acid sphingomyelinase from human urine: purification and characterization. Biochim. Biophys. Acta 922: 323–336.
   PubMedGoogle Scholar
• Rao, B. G., and M. W. Spence. 1976. Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J. Lipid Res. 17: 506–515.
   PubMed Web of Science ®Google Scholar
• Ridgway, N. D. 2000. Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim. Biophys. Acta 1484: 129–141.
   PubMedGoogle Scholar
• Rodrigues-Lima, F., A. C. Fensome, M. Josephs, J. Evans, R. J. Veldman, and M. Katan. 2000. Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities. Analysis by chemical modification and site-directed mutagenesis. J. Biol. Chem. 275: 28316–28325.
   PubMedGoogle Scholar
• Rossanese, O. W., and B. S. Glick. 2001. Deconstructing golgi inheritance. Traffic 2: 589–596.
   PubMedGoogle Scholar
• Ruiz-Arguello, M. B., F. M. Goni, and A. Alonso. 1998. Vesicle membrane fusion induced by the concerted activities of sphingomyelinase and phospholipase C. J. Biol. Chem. 273: 22977–22982.
   PubMedGoogle Scholar
• Sankaram, M. B., and T. E. Thompson. 1990. Interaction of cholesterol with various glycerophospholipids and sphingomyelin. Biochemistry 29: 10670–10675.
   PubMed Web of Science ®Google Scholar
• Sawai, H., N. Domae, N. Nagan, and Y. A. Hannun. 1999. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J. Biol. Chem. 274: 38131–38139.
   PubMedGoogle Scholar
• Sawai, H., Y. Okamoto, C. Luberto, C. Mao, A. Bielawska, N. Domae, and Y. A. Hannun. 2000. Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae. J. Biol. Chem. 275: 39793–39798.
   PubMedGoogle Scholar
• Schmidt, A., M. Wolde, C. Thiele, W. Fest, H. Kratzin, A. V. Podtelejnikov, W. Witke, W. B. Huttner, and H. D. Soling. 1999. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature 401: 133–141.
   PubMed Web of Science ®Google Scholar
• Schuchman, E. H., O. Levran, L. V. Pereira, and R. J. Desnick. 1992. Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 12: 197–205.
   PubMedGoogle Scholar
• Swiatek, P. J., and T. Gridley. 1993. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 7: 2071–2084.
   PubMed Web of Science ®Google Scholar
• Tepper, A. D., P. Ruurs, J. Borst, and W. J. van Blitterswijk. 2001. Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis. Biochem. Biophys. Res. Commun. 280: 634–639.
   PubMedGoogle Scholar
• Tomiuk, S., K. Hofmann, M. Nix, M. Zumbansen, and W. Stoffel. 1998. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. USA 95: 3638–3643.
   PubMedGoogle Scholar
• Tomiuk, S., M. Zumbansen, and W. Stoffel. 2000. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J. Biol. Chem. 275: 5710–5717.
   PubMedGoogle Scholar
• Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153–1163.
   PubMed Web of Science ®Google Scholar
• van Meer, G., and J. C. Holthuis. 2000. Sphingolipid transport in eukaryotic cells. Biochim. Biophys. Acta 1486: 145–170.
   PubMed Web of Science ®Google Scholar
• Veiga, M. P., J. L. Arrondo, F. M. Goni, and A. Alonso. 1999. Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys. J. 76: 342–350.
   PubMedGoogle Scholar
• Voss, A. K., T. Thomas, and P. Gruss. 1997. Germ line chimeras from female ES cells. Exp. Cell Res. 230: 45–49.
   PubMedGoogle Scholar
• Watts, J. D., M. Gu, S. D. Patterson, R. Aebersold, and A. J. Polverino. 1999. On the complexities of ceramide changes in cells undergoing apoptosis: lack of evidence for a second messenger function in apoptotic induction. Cell Death Differ. 6: 105–114.
   PubMedGoogle Scholar
• Watts, J. D., M. Gu, A. J. Polverino, S. D. Patterson, and R. Aebersold. 1997. Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc. Natl. Acad. Sci. USA 94: 7292–7296.
   PubMedGoogle Scholar
• Wiegmann, K., S. Schutze, T. Machleidt, D. Witte, and M. Kroenke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005–1015.
   PubMed Web of Science ®Google Scholar
• Ybe, J. A., D. E. Wakeham, F. M. Brodsky, and P. K. Hwang. 2000. Molecular structures of proteins involved in vesicle fusion. Traffic 1: 474–479.
   PubMedGoogle Scholar
• Zha, X., L. M. Pierini, P. L. Leopold, P. J. Skiba, I. Tabas, and F. R. Maxfield. 1998. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140: 39–47.
   PubMedGoogle Scholar